Evidence map›Paper›PMID 37554265›Full record

ArticleTheranostics2023

BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution.

Chengyan Chai, Ke Sui, Jun Tang, Hao Yu, Chao Yang, Hongyang Zhang, Shengwen Calvin Li, Jiang F Zhong, Zheng Wang, Xi Zhang

Abstract read
In one paragraph

Article in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Beyond the gap: moonlighting functions of connexins in cancer.Cell communication and signaling : CCS · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The functional role of exosomalTranslational cancer research · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Perspective and Therapeutic Potential of the Noncoding RNA-Connexin Axis.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chengyan ChaiMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Ke SuiMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Jun TangMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Hao YuMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Chao YangMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Hongyang ZhangMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Shengwen Calvin LiNeuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, CHOC Children's Research Institute, Children's Hospital of Orange County (CHOC), 1201 La Veta Ave., Orange, CA 92868-3874, United States of America.
Jiang F ZhongDepartment of Basic Sciences, Loma Linda University, Loma Linda, California, 92354, United States of America.
Zheng WangMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.
Xi ZhangMedical Center of Hematology, Second Affiliated Hospital, Army Medical University, Chongqing,400037, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Connexin 43ExosomesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMicroRNAsCell CommunicationHumansPhosphatidylinositol 3-KinasesTumor MicroenvironmentTumor Suppressor ProteinsConnexin 43GJA1 protein, humanMicroRNAsNDRG2 protein, humanPhosphatidylinositol 3-KinasesTumor Suppressor Proteinsacute lymphoblastic leukemiaBCR-ABL1B progenitor acute lymphoblastic leukemiachemotherapy resistanceCx43gap junctionsleukemic microenvironmentmiR-130a and miR-130bMSCsstemness

Identifiers

PMID37554265
PMCPMC10405834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.